Meeting the 2030 END TB goals in the wake of COVID-19: A modelling study of countries in the USAID TB portfolio.

Progress towards the 2030 End TB goals has seen severe setbacks due to disruptions arising from the COVID-19 pandemic. For governments and international partner organizations supporting the global TB response, there is a need to assess what level of effort is now needed to reach these goals. Using m...

Full description

Bibliographic Details
Main Authors: Nimalan Arinaminpathy, Ya Diul Mukadi, Amy Bloom, Cheri Vincent, Sevim Ahmedov
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLOS Global Public Health
Online Access:https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0001271&type=printable
_version_ 1797647746187919360
author Nimalan Arinaminpathy
Ya Diul Mukadi
Amy Bloom
Cheri Vincent
Sevim Ahmedov
author_facet Nimalan Arinaminpathy
Ya Diul Mukadi
Amy Bloom
Cheri Vincent
Sevim Ahmedov
author_sort Nimalan Arinaminpathy
collection DOAJ
description Progress towards the 2030 End TB goals has seen severe setbacks due to disruptions arising from the COVID-19 pandemic. For governments and international partner organizations supporting the global TB response, there is a need to assess what level of effort is now needed to reach these goals. Using mathematical modelling, we addressed this question for the countries being supported by the United States Agency for International Development (USAID). We aggregated the 24 countries in the USAID portfolio into three geographical country groups: South Asia; sub-Saharan Africa; and Central Asian Republics/Europe (CAR/EU). From 2023 onwards we modelled a combination of interventions acting at different stages of the care cascade, including improved diagnostics; reducing the patient care seeking delay; and the rollout of a disease-preventing vaccine from 2025 onwards. We found that in all three country groups, meeting the End TB goals by 2030 will require a combination of interventions acting at stages of the TB care cascade. Specific priorities may depend on country settings, for example with public-private mix playing an important role in countries in South Asia and elsewhere. When a vaccine becomes available, its required coverage to meet the 2030 goals will vary by setting, depending on the amount of preventive therapy that has already been implemented. Monitoring the number-needed-to-test to identify 1 person with TB in community settings can provide a useful measure of progress towards the End TB goals.
first_indexed 2024-03-11T15:20:57Z
format Article
id doaj.art-4bb704280b3b46ea94fe9872ddd25676
institution Directory Open Access Journal
issn 2767-3375
language English
last_indexed 2024-03-11T15:20:57Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLOS Global Public Health
spelling doaj.art-4bb704280b3b46ea94fe9872ddd256762023-10-28T05:56:02ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752023-01-01310e000127110.1371/journal.pgph.0001271Meeting the 2030 END TB goals in the wake of COVID-19: A modelling study of countries in the USAID TB portfolio.Nimalan ArinaminpathyYa Diul MukadiAmy BloomCheri VincentSevim AhmedovProgress towards the 2030 End TB goals has seen severe setbacks due to disruptions arising from the COVID-19 pandemic. For governments and international partner organizations supporting the global TB response, there is a need to assess what level of effort is now needed to reach these goals. Using mathematical modelling, we addressed this question for the countries being supported by the United States Agency for International Development (USAID). We aggregated the 24 countries in the USAID portfolio into three geographical country groups: South Asia; sub-Saharan Africa; and Central Asian Republics/Europe (CAR/EU). From 2023 onwards we modelled a combination of interventions acting at different stages of the care cascade, including improved diagnostics; reducing the patient care seeking delay; and the rollout of a disease-preventing vaccine from 2025 onwards. We found that in all three country groups, meeting the End TB goals by 2030 will require a combination of interventions acting at stages of the TB care cascade. Specific priorities may depend on country settings, for example with public-private mix playing an important role in countries in South Asia and elsewhere. When a vaccine becomes available, its required coverage to meet the 2030 goals will vary by setting, depending on the amount of preventive therapy that has already been implemented. Monitoring the number-needed-to-test to identify 1 person with TB in community settings can provide a useful measure of progress towards the End TB goals.https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0001271&type=printable
spellingShingle Nimalan Arinaminpathy
Ya Diul Mukadi
Amy Bloom
Cheri Vincent
Sevim Ahmedov
Meeting the 2030 END TB goals in the wake of COVID-19: A modelling study of countries in the USAID TB portfolio.
PLOS Global Public Health
title Meeting the 2030 END TB goals in the wake of COVID-19: A modelling study of countries in the USAID TB portfolio.
title_full Meeting the 2030 END TB goals in the wake of COVID-19: A modelling study of countries in the USAID TB portfolio.
title_fullStr Meeting the 2030 END TB goals in the wake of COVID-19: A modelling study of countries in the USAID TB portfolio.
title_full_unstemmed Meeting the 2030 END TB goals in the wake of COVID-19: A modelling study of countries in the USAID TB portfolio.
title_short Meeting the 2030 END TB goals in the wake of COVID-19: A modelling study of countries in the USAID TB portfolio.
title_sort meeting the 2030 end tb goals in the wake of covid 19 a modelling study of countries in the usaid tb portfolio
url https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0001271&type=printable
work_keys_str_mv AT nimalanarinaminpathy meetingthe2030endtbgoalsinthewakeofcovid19amodellingstudyofcountriesintheusaidtbportfolio
AT yadiulmukadi meetingthe2030endtbgoalsinthewakeofcovid19amodellingstudyofcountriesintheusaidtbportfolio
AT amybloom meetingthe2030endtbgoalsinthewakeofcovid19amodellingstudyofcountriesintheusaidtbportfolio
AT cherivincent meetingthe2030endtbgoalsinthewakeofcovid19amodellingstudyofcountriesintheusaidtbportfolio
AT sevimahmedov meetingthe2030endtbgoalsinthewakeofcovid19amodellingstudyofcountriesintheusaidtbportfolio